REVATIO (sildenafil) LIQREV (sildenafil) sildenafil . POLICY . I. INDICATIONS . The indications below including FDA-approved indications and compendial uses are considered a covered benefit provided that all the approval criteria are met and the member has no exclusions to the prescribed therapy. A. FDA-Approved Indications 1.
What is the generic name? SILDENAFIL. What is the Trade Name for SILDENAFIL? Sildenafil Citrate. What are the Indications for SILDENAFIL? 1. INDICATIONS AND USAGE Sildenafil tablets are phosphodiesterase-5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical
CIPLA USA INC,: Sildenafil tablets are indicated for the treatment of erectile dysfunction. Sildenafil tablets is a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile
Indications and Usage for Sildenafil Oral Suspension. Adults. Sildenafil for oral suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) (World
Sildenafil tablets, for oral use Sildenafil for oral suspension Initial U.S. Approval: 2025 INDICATIONS AND USAGE Sildenafil is a phosphodiesterase-5 (PDE-5) inhibitor indicated for
REMEDYREPACK INC.: Sildenafil tablets are indicated for the treatment of erectile dysfunction. Sildenafil citrate is a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile
Sildenafil is used for the treatment of digital ulcer, E but is not licensed for this indication. Contra-indications Contra-indications For sildenafil. General contra-indications:
Sildenafil is not indicated for use in females. Limited data indicate that sildenafil and its active metabolite are present in human milk. There is no information on the effects on the breastfed child, or the effects on milk production. 8.4 Pediatric Use. Sildenafil is not indicated for use in pediatric patients.
Indications and Usage for Sildenafil Tablets. Adults. Sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO]
Comments